396435000: Inactivated Poliovirus vaccine (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
inaktiveret poliovirusvaccine	Is a	vaccine	false	Inferred relationship	Some
inaktiveret poliovirusvaccine	Is a	Drug allergen	false	Inferred relationship	Some
inaktiveret poliovirusvaccine	Is a	poliovirusvaccine	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
inaktiveret poliovaccine injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	1
inaktiveret poliovirusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	1
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
difteri-/tetanus-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
difteri- + tetanus- + inaktiveret poliovirusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	1
difteri- + tetanus- + kighoste- + inaktiveret poliovirusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
lavdosis difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
højdosisdifteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
difteri-, acellulær kighoste-, hepatitis B- og inaktiveret poliovaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	3
difteri- + tetanus- + poliovaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulært kighostetoxoid 25 µg inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
difteri- + tetanus- + kighoste- + polio- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
difteri- + tetanus- + kighoste- + poliovaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus- + rekombinant Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	2
Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	3
Diphtheria/tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some
Diphtheria + acellular pertussis adsorbed + inactivated polio + tetanus toxoids vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	4
Administration of vaccine product containing only inactivated whole Human poliovirus antigen (procedure)	Direct substance	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	1
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	4
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	1
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	4
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	inaktiveret poliovirusvaccine	Inferred relationship	Some	5

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1785579012	Inactivated poliomyelitis vaccine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3745287012	Inactivated Poliovirus vaccine (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3745288019	Inactivated Poliovirus vaccine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3267511000005115	inaktiveret poliovirusvaccine	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)